US FDA clears Mabwell’s IND application to initiate phase IIa study of novel anti-ST2 monoclonal antibody, 9MW1911 to treat moderate-to-severe COPD: Shanghai Monday, December 29 ...
Don’t get too happy with threes – FDU ranks 2nd to last in all of college basketball at defending the three. This should ...